🇺🇸 Placlitaxel in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Atrial Fibrillation — 1 report (10%)
  2. Axonal Neuropathy — 1 report (10%)
  3. Bacteraemia — 1 report (10%)
  4. Blood Immunoglobulin E Increased — 1 report (10%)
  5. Chest Pain — 1 report (10%)
  6. Decreased Appetite — 1 report (10%)
  7. Demyelinating Polyneuropathy — 1 report (10%)
  8. Drug Effect Decreased — 1 report (10%)
  9. Drug Interaction — 1 report (10%)
  10. Dyspnoea — 1 report (10%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Placlitaxel approved in United States?

Placlitaxel does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Placlitaxel in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.